RNAM

Avidity Biosciences

Delisted

RNAM was delisted on the 26th of February, 2026.

1 hedge funds and large institutions have $236K invested in Avidity Biosciences in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 333 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
CFM
126
Capricorn Fund Managers
United Kingdom
MIM
127
MetLife Investment Management
New Jersey
NYLIM
128
New York Life Investment Management
New York
MCP
129
Mirador Capital Partners
California
FLC
130
Fifth Lane Capital
Texas
BFM
131
Boothbay Fund Management
New York
AGP
132
Artia Global Partners
Florida
Manulife (Manufacturers Life Insurance)
133
Manulife (Manufacturers Life Insurance)
Ontario, Canada
DekaBank Deutsche Girozentrale
134
DekaBank Deutsche Girozentrale
Germany
BGM
135
Burkehill Global Management
New York
Raymond James Financial
136
Raymond James Financial
Florida
BNP Paribas Asset Management
137
BNP Paribas Asset Management
France
CC
138
Centiva Capital
New York
RC
139
Rangeley Capital
Connecticut
CC
140
CIBRA Capital
United Kingdom
FIA
141
FNY Investment Advisers
New York
CCM
142
Cinctive Capital Management
New York
KCM
143
Kennedy Capital Management
Missouri
DCM
144
Driehaus Capital Management
Illinois
Renaissance Technologies
145
Renaissance Technologies
New York
IIM
146
INTECH Investment Management
Florida
Skandinaviska Enskilda Banken (SEB)
147
Skandinaviska Enskilda Banken (SEB)
Sweden
LIP
148
Lighthouse Investment Partners
Florida
SC
149
SummitTX Capital
Texas
Handelsbanken Fonder
150
Handelsbanken Fonder
Sweden